Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Clarifying the indications for adjuvant chemotherapy in muscle-invasive bladder cancer

Nature Clinical Practice Urology volume 4, pages 184–185 (2007)Cite this article

boxed-textYu RJ et al. (2006) Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 176: 493–499

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hautmann RE et al. (2006) Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 176: 486–492

    Article  Google Scholar 

  2. Madersbacher S et al. (2003) Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690–696

    Article  Google Scholar 

  3. Stein JP et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666–675

    Article  CAS  Google Scholar 

  4. Lehmann J et al. (2005) Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial. J Clin Oncol 23: 4963–4974

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Tamsin Osborne, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Urology, Klinikum Kassel GmbH, Mönchebergstraße 41-43, D-34125 Kassel, Germany albers@klinikum-kassel.de

Authors and Affiliations

  1. P Albers is a Professor of Urology and the Chairman of the Department of Urology at Klinikum Kassel, Kassel, Germany.,

    Peter Albers

Authors
  1. Peter Albers
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albers, P. Clarifying the indications for adjuvant chemotherapy in muscle-invasive bladder cancer. Nat Rev Urol 4, 184–185 (2007). https://doi.org/10.1038/ncpuro0736

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0736

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing